These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2853763)

  • 21. Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study.
    Bartoloni C; Dupont P; Feltkamp H; Johnston CI; Steinbach K; Zilcher H; Kaindl F
    Eur J Clin Pharmacol; 1988; 35(6):573-7. PubMed ID: 2906874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.
    Naslund TC; Merrell WJ; Nadeau JH; Wood AJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):699-703. PubMed ID: 2904312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ketanserin and metoprolol in the treatment of essential hypertension].
    Cerasola G; Contorno A; D'Ignoto G; Talamo AR; Vallone A; Zilietti T
    Clin Ter; 1990 Aug 15-31; 134(3-4):193-7. PubMed ID: 2147620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the acute sublingual administration of ketanserin in hypertensive patients.
    Aliberti G; D'Erasmo E; Oddo CM; Vecci E
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):697-9. PubMed ID: 1888692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictability of antihypertensive responsiveness and alpha-adrenoceptor antagonism during prazosin treatment.
    Elliott HL; Donnelly R; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1989 Nov; 46(5):576-83. PubMed ID: 2573445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of ketanserin in pre-eclamptic patients and its association with antihypertensive response.
    Hanff LM; Visser W; Steegers EA; Vulto AG
    Fundam Clin Pharmacol; 2005 Oct; 19(5):585-90. PubMed ID: 16176338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally dissolved ketanserin in acute treatment of hypertensive patients: a controlled study.
    Di Veroli C; Pastorelli R
    Drugs Exp Clin Res; 1989; 15(11-12):583-5. PubMed ID: 2700321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
    Rizzoni D; Castellano M; Beschi M; Agabiti-Rosei E
    Ann Ital Med Int; 1990; 5(4 Pt 2):489-96. PubMed ID: 2102136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure patterns in pregnant patients on oral ketanserin.
    Steyn DW; Odendaal HJ
    Cardiovasc J S Afr; 2001; 12(2):82-7. PubMed ID: 11447496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of action of the hypotensive effect of ketanserin.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ketanserin in patients with essential hypertension.
    Persson B; Pettersson A; Hedner T
    Eur J Clin Pharmacol; 1987; 32(3):259-65. PubMed ID: 3595699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of ketanserin in the treatment of arterial hypertension].
    Cricco L
    Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
    van der Starre PJ; Reneman RS
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketanserin and hydrochlorothiazide in the treatment of arterial hypertension.
    Soro S; Grassi A; Pasanisi F; Ferrara LA
    Jpn Heart J; 1991 May; 32(3):307-14. PubMed ID: 1920817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R; Fetkovska N; Pletscher A; Bühler FR
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension.
    Hedner T; Persson B
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):317S-323S. PubMed ID: 3046635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.